Bilde av Gram, Inger Torhild
Bilde av Gram, Inger Torhild
Professor Institutt for samfunnsmedisin inger.gram@uit.no +4777645360 92401177 Her finner du meg

Inger Torhild Gram


Stillingsbeskrivelse

Inger Torhild Gram er lege, og professor i forebyggende medisin og tilhører forskningsgruppa  Systemepidemiolgi. Gram forsker først og fremst på sammenhengen mellom røyking og kreft, for tidlig død, og fordeler av røykeslutt. Hun arbeider med dette i fem befolkningsstudier, (Tromsøundersøkelsen,  Kvinner og kreft,  Smoking and Cancer,UiT, den europeiske EPIC studien, den amerikanske Multietniske studien(MEC), og i flere globale samarbeidsprosjekt. Gram har arbeidet med tobakksforebygging og retningslinjer for røykfrihet siden 1990 tallet, lokalt på UiT, UNN, Tromsø Kommune og som medlem av Nasjonalt Råd for Tobakksforebygging. Gram arbeider også med endring av livsstil og forebygging av død fra kroniske sykdommer. Hun har formidlet forskningsresultater over hele verden til det vitenskapelige miljøet, gjennom foredrag på internasjonale konferanser, pressekonferanser, vitenskapelige publikasjoner og til helsemyndigheter, politikere og folk generelt i TV, radio og andre medier. Gram har vært fire år i forskningsrådet til  IARC ,[kreftforskningsbyrået til Verdens helseorganisasjon (WHO)].  Gram underviser på de fem første studieårene av profesjonsstudiet i medisin. Gram har en 20% stilling som professor ved Nasjonalt senter for e-helseforskning. Universitetssykehuset Nord Norge (UNN), Tromsø, WHO's samarbeidssenter for telemedisin.

 


  • Jinze Li, Jacqueline Roshelli Baker, Elom K. Aglago, Zhiwei Zhao, Li Jiao, Heinz Freisling m.fl.:
    Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients
    International Journal of Cancer 2024 DOI
  • Eo Rin Cho, IK Brill, Inger Torhild Gram, Patrick E. Brown, Prabhat Jha :
    Smoking Cessation and Short- and Longer-Term Mortality
    NEJM Evidence 2024 DOI
  • Anna Morra, Maartje A. C. Schreurs, Irene L. Andrulis, Hoda Anton-Culver, Annelie Augustinsson, Matthias W. Beckmann m.fl.:
    Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
    Cancer Medicine 2023 ARKIV / DOI
  • Clara García-Vicente, David Chushig-Muzo, Inmaculada Mora-Jimenez, Himar Fabelo, Inger Torhild Gram, Maja-Lisa Løchen m.fl.:
    Clinical Synthetic Data Generation to Predict and Identify Risk Factors for Cardiovascular Diseases
    Lecture Notes in Computer Science (LNCS) 2023 ARKIV / DOI
  • Joanna L. Clasen, Rita Mabunda, Alicia K. Heath, Rudolf Kaaks, Verena Katzke, Matthias B. Schulze m.fl.:
    Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition
    Cancer Medicine 2023 ARKIV / DOI
  • Ziling Mao, Jacqueline Roshelli Baker, Masayoshi Takeuchi, Hideyuki Hyogo, Anne Tjønneland, Anne Kirstine Eriksen m.fl.:
    Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients
    International Journal of Cancer 2023 DOI
  • Gisella Figlioli, Amandine Billaud, Thomas U. Ahearn, Natalia N. Antonenkova, Heiko Becher, Matthias W. Beckmann m.fl.:
    FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
    European Journal of Human Genetics 2023 ARKIV / DOI
  • Anna Morra, Nasim Mavaddat, Taru A. Muranen, Thomas U. Ahearn, Jamie Allen, Irene L. Andrulis m.fl.:
    The impact of coding germline variants on contralateral breast cancer risk and survival
    American Journal of Human Genetics 2023 ARKIV / DOI
  • Alejandro Deniz-Garcia, Himar Fabelo, Antonio J. Rodriguez-Almeida, Garlene Zamora-Zamorano, Maria Castro-Fernandez, Maria del Pino Alberiche Ruano m.fl.:
    Quality, Usability, and Effectiveness of mHealth Apps and the Role of Artificial Intelligence: Current Scenario and Challenges
    Journal of Medical Internet Research (JMIR) 2023 ARKIV / DOI
  • Clara García-Vicente, David Chushig-Muzo, Inmaculada Mora-Jiménez, Himar Fabelo, Inger Torhild Gram, Maja-Lisa Løchen m.fl.:
    Evaluation of Synthetic Categorical Data Generation Techniques for Predicting Cardiovascular Diseases and Post-Hoc Interpretability of the Risk Factors
    Applied Sciences 2023 ARKIV / DOI
  • Trasias Mukama, Renée Turzanski Fortner, Verena Katzke, Lucas Cory Hynes, Agnese Petrera, Stefanie M. Hauck m.fl.:
    Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer
    British Journal of Cancer 2022 ARKIV / DOI
  • Joe Dennis, Jonathan P. Tyrer, Logan C. Walker, Kyriaki Michailidou, Leila Dorling, Vessela N. Kristensen m.fl.:
    Rare germline copy number variants (CNVs) and breast cancer risk
    Communications Biology 2022 ARKIV / DOI
  • Ana-Lucia Mayén, Vivian Viallon, Edoardo Botteri, Cecile Proust-Lima, Vincenzo Bagnardi, Veronica Batista m.fl.:
    A longitudinal evaluation of alcohol intake throughout adulthood and colorectal cancer risk
    European Journal of Epidemiology (EJE) 2022 DOI
  • Inger Torhild Gram, Konstantinos Antypas, Silje C Wangberg, Maja-Lisa Løchen, Dillys Larbi :
    Factors associated with predictors of smoking cessation from a Norwegian internet-based smoking cessation intervention study
    Tobacco Prevention & Cessation 2022 ARKIV / DOI
  • Leila Dorling, Sara Carvalho, Jamie Allen, Michael T. Parsons, Cristina Fortuno, Vessela N. Kristensen m.fl.:
    Breast cancer risks associated with missense variants in breast cancer susceptibility genes
    Genome Medicine 2022 ARKIV / DOI
  • Reynalda Córdova, Ana-Lucia Mayén, Viktoria Knaze, Elom Kouassivi Aglago, Casper Schalkwijk, Karl-Heinz Wagner m.fl.:
    Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study
    Cancer Communications 2022 ARKIV / DOI
  • Manon Cairat, Sabina Rinaldi, Anne-Sophie Navionis, Isabelle Romieu, Carine Biessy, Vivian Viallon m.fl.:
    Circulating inflammatory biomarkers, adipokines and breast cancer risk—a case-control study nested within the EPIC cohort
    BMC Medicine 2022 ARKIV / DOI
  • Inger Torhild Gram, Guri Skeie, Sunday Oluwafemi Oyeyemi, Kristin Benjaminsen Borch, Laila Arnesdatter Hopstock, Maja-Lisa Løchen :
    A Smartphone-Based Information Communication Technology Solution for Primary Modifiable Risk Factors for Noncommunicable Diseases: Pilot and Feasibility Study in Norway
    JMIR Formative Research 2022 ARKIV / DOI
  • Inger Torhild Gram, Song-Yi Park, Lynne R. Wilkens, Loïc Le Marchand, Veronica Wendy Setiawan :
    Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study
    Cancer Causes and Control 2022 ARKIV / DOI
  • Karl Smith-Byrne, Agustin Cerani, Florence Guida, Sirui Zhou, Antonio Agudo, Krasimira Aleksandrova m.fl.:
    Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements
    Cancer Epidemiology, Biomarkers and Prevention 2022 ARKIV / DOI
  • Niki Dimou, Wemimo Omiyale, Carine Biessy, Vivian Viallon, Rudolf Kaaks, Tracy A. O'Mara m.fl.:
    Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses
    Cancer Epidemiology, Biomarkers and Prevention 2022 ARKIV / DOI
  • Julia Butt, Mazda Jenab, Jill Werner, Veronika Fedirko, Elisabete Weiderpass, Christina C. Dahm m.fl.:
    Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort
    Gut microbes 2021 ARKIV / DOI
  • Jacqueline Roshelli Baker, Sushma Umesh, Mazda Jenab, Lutz Schomburg, Anne Tjønneland, Anja Olsen m.fl.:
    Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations
    Biomedicines 2021 ARKIV / DOI
  • Ziling Mao, Elom K. Aglago, Zhiwei Zhao, Casper C Schalkwijk, Li Jiao, Heinz Freisling m.fl.:
    Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer
    Nutrients 2021 ARKIV / DOI
  • Catalina Londono, Valerie Cayssials, Izar de Villasante, Marta Crous-Bou, Augustin Scalbert, Elisabete Weiderpass m.fl.:
    Polyphenol Intake and Epithelial Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
    Antioxidants 2021 ARKIV / DOI
  • Rosie K. Singleton, Alicia K. Heath, Joanna L. Clasen, Ghislaine Scelo, Mattias Johansson, Florence Le Calvez-Kelm m.fl.:
    Risk prediction for renal cell Carcinoma: Results from the European Prospective Investigation into Cancer and nutrition (EPIC) prospective cohort study
    Cancer Epidemiology, Biomarkers and Prevention 2021 DOI
  • Jakob Linseisen, Nina Grundmann, Dorothee Zoller, Tilman Kühn, Eugéne H.J.M. Jansen, Veronique Chajes m.fl.:
    Red blood cell fatty acids and risk of colorectal cancer in the European Prospective investigation into cancer and nutrition (EPIC)
    Cancer Epidemiology, Biomarkers and Prevention 2021 DOI
  • Carlota Castro-Espin, Antonio Agudo, Catalina Bonet, Verena Katzke, Renée Turzanski-Fortner, Aleksandrova Krasimira m.fl.:
    Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study
    European Journal of Epidemiology (EJE) 2021 DOI
  • Elom Kouassivi Aglago, Neil Murphy, Inge Huybrechts, Geneviève Nicolas, Corinne Casagrande, Veronika Fedirko m.fl.:
    Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
    International Journal of Cancer 2021 DOI
  • Nagisa Mori, Pekka Keski-Rahkonen, Audrey Gicquiau, Sabina Rinaldi, Niki Dimou, Sophia Harlid m.fl.:
    Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis
    JNCI Cancer Spectrum 2021 ARKIV / DOI
  • Espen Aas, Inger Torhild Gram, Even A. Røed :
    Dagsnytt atten.Strid om e-sigaretter.
    12. januar 2024 DATA
  • Steinar Solberg, Inger Torhild Gram, Maja-Lisa Løchen :
    E-sigaretter er en trussel mot folks helse
    Aftenposten (morgenutg. : trykt utg.) 08. januar 2024
  • Garlene Zamora Zamorano, Alejandro Déniz Garcia, Alezandra Torres-Castaño, Maria Luisa Álvarez-Malé, Inger Torhild Gram, Guri Skeie m.fl.:
    EL PANORAMA DE LAS APLICACIONES MÓVILES PARA UNA ALIMENTACIÓN SALUDABLE: UNA REVISIÓN SISTEMÁTICA Y EVALUACIÓN DE LA CALIDAD
    2024
  • Inger Torhild Gram :
    Disease prevention versus disease management - different concepts/methods – same goal.
    2023
  • Inger Torhild Gram, Sondre Opedal :
    Hyller røykeslutt-teknikk: Metoden som fungerer.
    02. februar 2023 DATA
  • Inger Torhild Gram :
    Kan røyking øke risikoen for å få brystkreft?
    2023 DATA
  • Inger Torhild Gram :
    Snus og røykeslutt
    2023
  • Inger Torhild Gram, Randi Laukli :
    Snuser du? Da er sjansen stor for å mislykkes med å stumpe røyken for godt
    01. januar 2023 FULLTEKST
  • Inger Torhild Gram, Sondre Opedal :
    Metoden som hjelper deg å kutte røyken
    08. februar 2023
  • Kristine Thrane, Inger Torhild Gram :
    Ekspertene krangler om snus gjør det lettere å stumpe røyken
    04. januar 2023 FULLTEKST
  • Inger Torhild Gram :
    Rökare bör varnas för snus som rökavvänjning
    2023 DATA
  • Inger Torhild Gram, Maja-Lisa Løchen :
    Smarttelefoner kan enkelt bidra til å redusere dødeligheten blant voksne i Norge og de fleste andre land.
    UiT Forskerhjørnet 20. april 2022 DATA
  • Inger Torhild Gram :
    Hazards of smoking and benefits of smoking cessation by sex and pancreatic cancer; the Multiethnic Cohort
    2022
  • Inger Torhild Gram, Song-Yi Park, Lynne R Wilkens, Loïc Le Marchand, Veronica W. Setiawan :
    Smoking and Pancreatic Cancer in the Multiethnic Cohort study
    Norsk Epidemiologi, Supplement 26. oktober 2022
  • Inger Torhild Gram :
    Smoking and Pancreatic Cancer in the Multiethnic Cohort study
    2022
  • Clara García-Vicente, David Chushig-Muzo, Mora-Jiménez Inmaculada, Inger Torhild Gram, Maja-Lisa Løchen, Himar Fabelo m.fl.:
    Clinical synthetic data generation to predict and identify risk factors for cardiovascular diseases
    2022
  • Inger Torhild Gram, Anne Lise Stranden :
    Jenter som utsettes for passiv røyking, har økt risiko for brystkreft som voksen
    25. september 2021 DATA
  • Ida Rønning, Inger Torhild Gram :
    Ny forskningsrapport slår kreftalarm etter alkoholfunn.
    15. juli 2021 DATA
  • Ida Rønning, Inger Torhild Gram :
    Slår kreftalarm etter alkoholfunn
    15. juli 2021
  • Inger Torhild Gram, Arne Bastian Wiik, Eiliv Lund, Idlir Licaj, Tonje Bjørndal Braaten :
    Never smokers and exposure to second hand smoke (SHS) from parents during childhood and risk of Breast Cancer. The Norwegian Women and Cancer study 1991-2018
    2021

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →

    Publikasjoner utenom Cristin

       


    Undervisning

    • Underviser for tiden på de fem første årene av profesjonsstudiet i medisin. 
    • Lang erfaring som underviser i epidemiologi, forebyggende medisin, folkehelse, profesjonell kompetanse og kunnskapshåndtering ved profesjonsstudiet i medisin og som underviser ved profesjonsstudiet i odontologi og farmasi og ved master i folkehelse studiet (MPH).  

    Hovedveileder

    • 2007 Yngve Bremnes MD, PhD: Hormones, smoking and mammographic density in postmenopausal Norwegian women : the Tromsø Mammography and Breast Cancer Study
    • 2014 Ranjan Parajuli, MD, PhD:  Smoking and incidence and mortality of colorectal cancer
    • 2014 Eivind Bjerkaas, MD, PhD: Aspects of Active Smoking and Breast Cancer
    • 2015 Postdoktor Idlir Ilicaj.
    • 2020 Merethe Selnes Hansen, MD, PhD: Aspects of Lung Cancer by Sex.  


    CV

    Kort CV - se CV på den engelske siden her